1.
Garcia-Manero G, Faderl S, Giles F, Thomas D, Cortes J, O’Brien S, Davis J, Kantarjian H, Estey E. A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes. Haematologica [Internet]. 2002Aug.1 [cited 2026Nov.19];87(8):804-7. Available from: https://haematologica.org/article/view/2461